Filing Flows › Companies › Abbott Laboratories › Timeline
Abbott Laboratories stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions−9.8% to $109.93
Abbott Laboratories (ABT) stock fell 10% over the last 252 sessions, to $109.93. On the way it reported 0 quarters, its insiders filed 1 open-market trade and 3 Form 144 notices of planned sales, and the company filed 5 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 5, 2026 | Form 144 | Form 144: Mary K. Moreland plans to sell $406K | −1.7% (+2.8% vs SPY) | — | — |
| Nov 5, 2026 | Insider sale | Moreland Mary K sold $406K | −1.7% (+2.8% vs SPY) | — | — |
| Aug 25, 2026 | Form 144 | Form 144: Robert B. Ford plans to sell $46.2M | −0.5% (−0.8% vs SPY) | −5.5% (−6.0% vs SPY) | −11.9% (−12.7% vs SPY) |
| Aug 11, 2026 | Form 144 | Form 144: Louis H. Morrone plans to sell $643K | +1.0% (+1.3% vs SPY) | +1.6% (+1.6% vs SPY) | −3.1% (−1.7% vs SPY) |
| Apr 27, 2026 | 8-K | Directors and officers: departures, appointments, pay | +1.1% (+1.6% vs SPY) | −5.8% (−6.2% vs SPY) | −8.0% (−12.8% vs SPY) |
| Mar 9, 2026 | 8-K | Material definitive agreement | −1.9% (−1.7% vs SPY) | −2.4% (−1.0% vs SPY) | −8.4% (−8.4% vs SPY) |
| Feb 26, 2026 | 8-K | Material definitive agreement | +0.1% (+0.6% vs SPY) | −4.6% (−3.4% vs SPY) | −11.2% (−3.1% vs SPY) |
| Dec 12, 2025 | 8-K | Directors and officers: departures, appointments, pay | +2.4% (+2.5% vs SPY) | 0.0% (−0.1% vs SPY) | −0.4% (−1.9% vs SPY) |
| Nov 20, 2025 | 8-K | Material definitive agreement | −1.7% (−0.2% vs SPY) | +1.9% (−0.7% vs SPY) | −0.6% (−3.5% vs SPY) |
Insiders’ record here
In the year on the chart, Abbott Laboratories' insiders reported 0 open-market buys ($0) and 1 sale ($406K).
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Abbott Laboratories: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.